The company, recently valued at $49bn, is 12 months away from bankruptcy
Dmytro Chepur - 15 august 2023
An overview of the main events of the past seven days and the international press' reaction to them
Vladyslav Osypenko - 14 august 2023
Darnytsia will occupy a new niche in the production of vaccines against Covid-19. It also plans to join the development of drugs for tuberculosis and HIV
Kateryna Khutorna - 14 august 2023
Where the funds will go and what about competitors
Aliona Sidelnikova - 4 august 2023
The rise in average temperatures on the planet has a clear economic effect – with a negative indicator for many areas
Vitaliі Kravchenko - 4 august 2023
And what the business asks to change in the tax ideas of MPs
Pavlo Harlamov - 1 august 2023
How to approach them for businesses from Ukraine
Dmytro Shvets - 1 august 2023
Will the team succeed in raising funds and becoming a meta university for shooters?
Aliona Sidelnikova - 21 july 2023
However, only a few have utilised it. Why did this happen?
Oleksandr Dereka - 21 july 2023
Do Ukrainians need 'pet' devices during the war?
Aliona Sidelnikova - 20 july 2023
